Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

Review Series

108 series available.
  • ← Previous
  • 1
  • 2
  • …
  • 9
  • 10
  • 11
  • Next →

Stem cell biology

Series edited by Pamela Robey

The series reviews the broad array of stem cell types and stimulate discussion of the controversies and challenges that face the field. The articles suggest that a new conceptual framework is needed for thinking about stem cells and their therapeutic potential.

Published January 2000


Tissue responses to ischemia

Series edited by Gregg L. Semenza

Ischemia arises when demands for energy substrates (primarily oxygen and glucose) are not matched by supply. The consequences differ depending on the affected tissue, and the series covers the effects of ischemia in a number of different tissues and organs.

Published January 2000


Targets for cancer therapy

Series edited by William G Kaelin Jr.

The series reviews a number of cellular processes that provide cancer drug targets, including angiogenesis, cell cycle and checkpoint control, growth factor signaling, and apoptosis. It also discusses target selection based on genomics and the specific case of the Abl inhibitor Gleevec.

Published December 1999


Alzheimer's disease

Series edited by Sangram Sisodia

Articles in the series highlight recent advances pertaining to the accuracy of clinico-pathological diagnoses, genetic risk factors, mechanisms of disease, and therapeutic strategies, and point to areas for future investigations.

Published November 1999


Asthma

Series edited by Jack A. Elias

The series summarizes recent advances in elucidating the molecular and cellular etiology of asthma. Specific topics covered include the roles of IgE, chemokines, and Th2 cells, as well as early life origins of the disease and airway remodeling seen in patients.

Published October 1999


Angiogenesis

Series edited by David Cheresh

Therapeutic manipulation of angiogenesis would be desirable for the treatment of a variety of diseases, including cancer and heart disease. This short series focuses this therapeutic potential and specifically on integrins and matrix metalloproteinases as potential targets.

Published May 1999


Protein-protein interaction domains in signal transduction

Series edited by Alan R. Saltiel and Benjamin L. Margolis

Signal transduction depends on a series of direct interaction between molecules, both on the cell surface and intracellularly. The series discusses the molecular basis for the formation of transient protein complexes.

Published March 1999


Cystic fibrosis

Series edited by James M. Wilson

This series summarizes the current knowledge of the molecular basis for cystic fibrosis and reviews the state of gene therapeutic and pharmacological strategies for therapeutic intervention.

Published February 1999


  • ← Previous
  • 1
  • 2
  • …
  • 9
  • 10
  • 11
  • Next →
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts